These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 31131028)
1. Immunopathological properties of the Schmidt AM; Escher U; Mousavi S; Tegtmeyer N; Boehm M; Backert S; Bereswill S; Heimesaat MM Gut Pathog; 2019; 11():24. PubMed ID: 31131028 [TBL] [Abstract][Full Text] [Related]
2. Protease Activity of Schmidt AM; Escher U; Mousavi S; Boehm M; Backert S; Bereswill S; Heimesaat MM Front Cell Infect Microbiol; 2019; 9():79. PubMed ID: 30984628 [TBL] [Abstract][Full Text] [Related]
3. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Heimesaat MM; Alutis M; Grundmann U; Fischer A; Tegtmeyer N; Böhm M; Kühl AA; Göbel UB; Backert S; Bereswill S Front Cell Infect Microbiol; 2014; 4():77. PubMed ID: 24959425 [TBL] [Abstract][Full Text] [Related]
4. Peptidase PepP is a novel virulence factor of Heimesaat MM; Schmidt AM; Mousavi S; Escher U; Tegtmeyer N; Wessler S; Gadermaier G; Briza P; Hofreuter D; Bereswill S; Backert S Gut Microbes; 2020 Nov; 12(1):1770017. PubMed ID: 32584649 [TBL] [Abstract][Full Text] [Related]
5. Immune responses upon Bereswill S; Grundmann U; Alutis ME; Fischer A; Kühl AA; Heimesaat MM Gut Pathog; 2017; 9():33. PubMed ID: 28592996 [TBL] [Abstract][Full Text] [Related]
6. Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model. Mousavi S; Schmidt AM; Escher U; Kittler S; Kehrenberg C; Thunhorst E; Bereswill S; Heimesaat MM Gut Pathog; 2020; 12():2. PubMed ID: 31921356 [TBL] [Abstract][Full Text] [Related]
7. Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S Front Cell Infect Microbiol; 2017; 7():322. PubMed ID: 28752081 [TBL] [Abstract][Full Text] [Related]
9. The IL-23/IL-22/IL-18 axis in murine Campylobacter jejuni infection. Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Göbel UB; Bereswill S Gut Pathog; 2016; 8():21. PubMed ID: 27385977 [TBL] [Abstract][Full Text] [Related]
10. Oral curcumin ameliorates acute murine campylobacteriosis. Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S Front Immunol; 2024; 15():1363457. PubMed ID: 38855111 [TBL] [Abstract][Full Text] [Related]
11. Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Kløve S; Genger C; Weschka D; Mousavi S; Bereswill S; Heimesaat MM Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33261211 [TBL] [Abstract][Full Text] [Related]
12. Impact of Campylobacter jejuni cj0268c knockout mutation on intestinal colonization, translocation, and induction of immunopathology in gnotobiotic IL-10 deficient mice. Heimesaat MM; Lugert R; Fischer A; Alutis M; Kühl AA; Zautner AE; Tareen AM; Göbel UB; Bereswill S PLoS One; 2014; 9(2):e90148. PubMed ID: 24587249 [TBL] [Abstract][Full Text] [Related]
13. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM PLoS One; 2012; 7(7):e40761. PubMed ID: 22808254 [TBL] [Abstract][Full Text] [Related]
14. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. Bereswill S; Fischer A; Plickert R; Haag LM; Otto B; Kühl AA; Dasti JI; Zautner AE; Muñoz M; Loddenkemper C; Gross U; Göbel UB; Heimesaat MM PLoS One; 2011; 6(6):e20953. PubMed ID: 21698299 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of intestinal and systemic sequelae of murine Ekmekciu I; Fiebiger U; Stingl K; Bereswill S; Heimesaat MM Gut Pathog; 2017; 9():17. PubMed ID: 28413453 [TBL] [Abstract][Full Text] [Related]
16. Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota. Shayya NW; Foote MS; Langfeld LQ; Du K; Bandick R; Mousavi S; Bereswill S; Heimesaat MM Eur J Microbiol Immunol (Bp); 2023 Jan; 12(4):107-122. PubMed ID: 36633627 [TBL] [Abstract][Full Text] [Related]
17. Combination of organic acids benzoate, butyrate, caprylate, and sorbate provides a novel antibiotics-independent treatment option in the combat of acute campylobacteriosis. Du K; Foote MS; Mousavi S; Buczkowski A; Schmidt S; Peh E; Kittler S; Bereswill S; Heimesaat MM Front Microbiol; 2023; 14():1128500. PubMed ID: 37007531 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical Mousavi S; Lobo de Sá FD; Schulzke JD; Bücker R; Bereswill S; Heimesaat MM Front Immunol; 2019; 10():2094. PubMed ID: 31552040 [TBL] [Abstract][Full Text] [Related]
19. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Haag LM; Fischer A; Otto B; Grundmann U; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM Eur J Microbiol Immunol (Bp); 2012 Mar; 2(1):2-11. PubMed ID: 24611115 [TBL] [Abstract][Full Text] [Related]
20. Immune-modulatory Properties of the Octapeptide NAP in Heimesaat MM; Mousavi S; Kløve S; Genger C; Weschka D; Giladi E; Bereswill S; Gozes I Microorganisms; 2020 May; 8(6):. PubMed ID: 32466564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]